Rated 5 out of 5 Dana Driggs (verified owner) Verified review - view original Amazing

You should contact your GP or healthcare provider if you experience: Persistent green stools lasting more than a week without obvious dietary explanation Black, tarry stools (melaena), which may indicate upper gastrointestinal bleeding Bright red blood in stools (haematochezia) or on toilet paper Pale, clay-coloured, or white stools , which could suggest bile duct obstruction or liver problems Diarrhoea lasting more than 48 hours , particularly if accompanied by dehydration symptoms Severe abdominal pain , especially if localised to the upper abdomen and radiating to the back, which could indicate pancreatitis (a rare but serious side effect of GLP-1 receptor agonists) Right upper quadrant pain , particularly after fatty meals, which may suggest gallbladder problems Yellowing of the skin or eyes (jaundice) with dark urine, which could indicate liver or gallbladder issues Signs of dehydration: excessive thirst, dark urine, dizziness, reduced urination, or dry mouth Persistent vomiting preventing adequate fluid or medication intake Unexplained weight loss beyond expected therapeutic effects Fever accompanying stool changes , suggesting possible infection For urgent but non-emergency concerns, contact NHS 111

The two together contributed US$11.028 billion in revenue, accounting for about 34% of Eli Lilly's total revenue in the first three quarters
Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 milligram and 4 mg doses at $149 per month for self-paying patients in an intensely competitive weight-loss drug market
The metabolic reset that thyroid patients need Here is what makes GLP-1 therapy particularly relevant for Hashimoto's patients